Skip to Main Content

Businesses

How Leading Life Sciences and BioTech Companies Reduce Musculoskeletal Injuries Through On-Site Workplace Health Programs

Featuring Cepheid, Beckman Coulter & Edwards Life Sciences

Industry: Biotechnology | Diagnostics | Medical Device Manufacturing

Solution: On-Site MSK Solutions | Injury Prevention | Ergonomics | Workforce Wellness

The Challenge

Life sciences organizations depend on highly skilled employees performing precise, repetitive work. Laboratory testing, manufacturing operations, equipment assembly, material handling, and extended standing can create significant musculoskeletal demands throughout the workforce.

Organizations such as Cepheid, Beckman Coulter, and Edwards Life Sciences, sought solutions that could improve employee access to care, support injury prevention efforts, and promote workforce well-being while aligning with broader safety and operational objectives.

The ART Solution

ART Corporate Solutions implemented on-site musculoskeletal health programs across multiple facilities, providing employees with direct access to treatment and injury prevention resources within the workplace.

Key program components included:

  • 14 years of experience servicing diverse organizational landscapes in the biotech industry
  • On-site musculoskeletal treatment
  • Manual soft-tissue therapy
  • Early intervention and symptom management
  • Workforce health reporting and program analytics

The goal was simple: make care accessible, encourage early reporting of discomfort, and support employees before issues developed into recordable injuries or lost productivity.

Results Across Multiple Life Sciences Locations

Program Reach

  • More than 8,700 employee treatments delivered
  • Support provided across multiple facilities
  • Strong employee engagement and utilization
  • Average case resolution in approximately 3-4 visits

Workforce Benefits

Participating organizations experienced:

  • Improved access to musculoskeletal care
  • Increased utilization of wellness resources
  • Earlier intervention for emerging symptoms
  • Reduced need for employees to leave work for treatment
  • Greater employee awareness of injury prevention strategies

Supporting Safety & Compliance Objectives

The program aligned with organizational goals related to:

  • OSHA recordable reduction
  • Musculoskeletal injury prevention
  • Ergonomic risk management
  • Occupational health programs
  • Workforce wellness initiatives
  • Employee engagement and retention

Why On-Site MSK Programs Work

The experiences of Cepheid, Beckman Coulter, and Edwards Life Sciences demonstrate that effective workplace health strategies share several common characteristics:

  • Treatment is available where employees work
  • Musculoskeletal concerns are addressed early
  • Ergonomics and treatment work together
  • Employee participation is encouraged through easy access
  • Outcomes and utilization are measured over time

Key Takeaway

For biotechnology, diagnostics, and medical device organizations, reducing musculoskeletal injury risk requires more than reactive care. By combining ergonomics, on-site treatment, employee education, and early intervention, employers can support workforce wellness, strengthen injury prevention efforts, and create healthier, more productive workplaces.

Key Outcome

Trusted by organizations across the diagnostics, medical device, biotechnology, and life sciences sectors since 2014

treatments delivered across 3 Cepheid locations

treatments on average for resolution per standard case at Beckman Coulter

The path to performance, relief, and recovery starts here.